Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia
Please always quote using this URN: urn:nbn:de:bvb:20-opus-115313
- No abstract available.
| Author: | Catharina Müller-Thomas, Martina Rudelius, Ina-Christine Rondak, Torsten Haferlach, Julie Schanz, Christina Huberle, Burkard Schmidt, Rainer Blaser, Marcus Kremer, Christian Peschel, Ulrich Germing, Uwe Platzbecker, Katharina Goetze |
|---|---|
| URN: | urn:nbn:de:bvb:20-opus-115313 |
| Document Type: | Journal article |
| Faculties: | Medizinische Fakultät / Pathologisches Institut |
| Language: | English |
| Parent Title (English): | HAEMATOLOGICA |
| ISSN: | 1592-8721 |
| Year of Completion: | 2014 |
| Volume: | 99 |
| Issue: | 10 |
| Pagenumber: | E179-E181 |
| Source: | Haematologica 2014; 99:e179-e181. DOI 10.3324/haematol.2014.104760 |
| DOI: | https://doi.org/10.3324/haematol.2014.104760 |
| Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
| Tag: | DEL(5Q); MDS; TP53 mutations; azacitidine; karyotype; p53 expression; prognosis; scoring system |
| Release Date: | 2015/07/14 |
| Licence (German): |  Deutsches Urheberrecht |